BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11242646)

  • 21. [Cooperative study of surgical adjuvant chemotherapy of colorectal carcinoma (second study): 3-year survival after surgery of non-curatively resected patients. Cooperative Study Group of Surgical Adjuvant Chemotherapy of Colorectal Cancer in Japan].
    Kunitomo K; Kikuchi K; Inokuchi K; Komi N; Hattori T; Taguchi T; Kondo T; Abe O; Uchino J; Ogawa N
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3409-15. PubMed ID: 2508567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy of gastric cancer with oral UFT (a mixture of uracil and fturafur) during the waiting period for surgery.
    Nio Y; Sato Y; Nagami H; Teramoto M; Inoue Y; Yano S; Sumi S; Tamura K; Fukumoto M
    Anticancer Res; 1998; 18(1B):523-30. PubMed ID: 9568172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur.
    Grau JJ; Domingo-Domenech J; Morente V; Pera M; Garcia-Valdecasas JC; Fuster J; Bombí A; Mellado B; Albanell J; Gascón P
    Oncology; 2004; 66(3):226-33. PubMed ID: 15218314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
    Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
    Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
    Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
    Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
    J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer.
    Grau JJ; Martín M; Fuster J; Pera M; García-Valdecasas JC; Bombí JA; Bordas JM; Alcobendas F; Grande L; Estapé J
    J Surg Oncol; 2003 Apr; 82(4):234-40. PubMed ID: 12672007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrasting effects of extended low dose versus standard dose shorter course UFT chemotherapy on microscopic versus macroscopic established tumors: implications for optimal postoperative adjuvant chemotherapy.
    Uchida J; Okabe H; Nakano K; Fujioka A; Saito H; Sugimoto Y; Oka T; Fukushima M
    Oncol Rep; 2007 Aug; 18(2):313-9. PubMed ID: 17611650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term chemotherapy in patients with stage IV gastric cancer after surgical treatment--a randomized comparative study of FT-207 and UFT].
    Sugimachi K; Okamura T; Furusawa M; Saku M; Noda S; Matsusaka T; Teraoka H; Toda T; Oka N; Inokuchi K
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2953-7. PubMed ID: 3140734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute study.
    Nio Y; Koike M; Omori H; Hashimoto K; Itakura M; Yano S; Higami T; Maruyama R
    Anticancer Res; 2004; 24(3b):1879-87. PubMed ID: 15274369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)].
    Kasai Y; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Abe O; Ito I; Nakajima T; Muto T; Kikuchi K; Sugie S; Hayasaka A
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1449-60. PubMed ID: 6820917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multihospital randomized study on pre- and post-operative adjuvant chemotherapy for colorectal cancer (Part 2)].
    Ishikawa H; Tomita M; Shimoyama T; Hirano T; Nakagoe T; Shimizu T; Kusano H; Eida K; Ishii T; Kotake Y
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):277-82. PubMed ID: 1899550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide].
    Kato M; Kinoshita K; Sawa T; Yoshimitsu S; Tomita F; Takano Y; Segawa M; Ohyama S; Yonemura Y; Miwa K
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):391-6. PubMed ID: 2106835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Postoperative adjuvant chemotherapy using NCS (neocarzinostatin) and 5-FU in the treatment of gastric cancer. First report--A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU].
    Yokomori T; Taniguchi T; Iesato H; Sakata Y; Watanabe T; Kawabe K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3064-70. PubMed ID: 2960267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Randomized controlled trial of MMC + UFT and MMC + 5-FU therapy in advanced gastric cancer].
    Sasagawa T; Ho N; Endo T; Sekine T; Sugiyama K; Tomidokoro T; Hatakeyama S; Togashi M; Onuki K; Katagiri J
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1179-85. PubMed ID: 8031159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [UFTPM (UFT + CDDP + MMC) therapy for progressive stomach cancer. Research Association of Progressive Stomach Cancer].
    Iwazaki R; Yasutake K; Fukuyama Y; Hasegawa K; Koizumi W; Sasai T; Kurihara M; Kubo Y; Ishikawa K; Hayakawa M
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1179-85. PubMed ID: 8333746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of adjuvant chemotherapy for patients with early gastric cancer].
    Sasaki A; Furusawa M; Tomoda H; Seo Y; Ohno S; Matsukuma A; Morita M; Kakeji Y
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):37-45. PubMed ID: 8291914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
    Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
    J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.